ClinicalTrials.Veeva

Menu
N

Noble Clinical Research | Tucson, AZ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ESK-001
ACT-541468
CNTX-4975-05
TAK-279
Lorundrostat
Vibegron
Elagolix
Tanezumab
FX006
Daridorexant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

14 of 62 total trials

53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

53-Week Study Evaluating the Safety and Efficacy of Intra-articular (IA) Injections of TPX-100 vs Placebo in Subjects with Mild to Severe Tibio-Femor...

Active, not recruiting
Osteoarthritis (OA) of the Knee
Drug: TPX-100 200mg, Once weekly for 4 weeks
Other: PBS

The goal of this clinical trial is to assess the safety and immunogenicity of an srRNA-based vaccine, JCXH-105, in the prevention of Herpes Zoster (S...

Active, not recruiting
Herpes Zoster (HZ)
Shingles
Biological: Shingrix
Biological: JCXH-105

TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for athero...

Enrolling
Diabetes Mellitus, Type 2
Metabolic Syndrome
Device: The Cleerly CAD Staging System

X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult part...

Active, not recruiting
Bipolar II Disorder
Bipolar I Disorder
Drug: Placebo
Drug: Azetukalner

The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...

Active, not recruiting
Plaque Psoriasis
Drug: TAK-279
Locations recently updated

This is a parallel-group, Phase 3, double-blind, 2-arm study to investigate the efficacy, safety, PK and PD of oral rilzabrutinib in achieving durabl...

Enrolling
Autoimmune Haemolytic Anaemia
Drug: rilzabrutinib
Drug: placebo

The purpose of this clinical study is to learn about the safety and effects of berobenatide (PF-08653944) for the treatment of knee osteoarthritis in...

Enrolling
Diabetes Melliuts, Type 2
Overweight and/or Obesity
Drug: Berobenatide
Drug: Placebo

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only
OSA
Drug: Aroxybutynin and Atomoxetine

The objective of the ESK-001-018 long term extension is to evaluate the safety and efficacy of ESK-001 over time. The scientific questions it aims to...

Active, not recruiting
Psoriasis
Severe Psoriasis
Drug: Open-Label Envudeucitinib
Drug: Blinded Envudeucitinib

This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypert...

Active, not recruiting
Hypertension
Drug: lorundrostat
Drug: Placebo

This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneu...

Active, not recruiting
Pneumococcal Immunization
Biological: Varivax
Biological: M-M-R II vaccine

Generalized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately t...

Enrolling
Generalized Anxiety Disorder (GAD)
Drug: Antidepressant Therapy (ADT)
Drug: ABBV-932

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting
Lower Respiratory Tract Illness
Biological: RSVpreF
Biological: Placebo

This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilintide is a...

Active, not recruiting
Overweight
Obesity
Drug: Cagrilintide
Drug: Placebo (matched to Cagrilintide)

Trial sponsors

Moderna logo
Pfizer logo
Sanofi logo
AbbVie logo
Idorsia Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo
A
Apnimed logo
C
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems